Effects of sc<scp>FOS</scp> on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double blind, placebo controlled study
Fernando Azpiroz(Universitat Autònoma de Barcelona), Michel Dapoigny(University of Clermont Auvergne), Jordi Serra(Vall d'Hebron Hospital Universitari), Annick Bernalier‐Donadille(Centre de Recherche en Nutrition Humaine d'Auvergne), Anna Accarino(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), F. Respondek(Korea Electric Power Corporation (South Korea)), Anne Wagner(École des Mines de Douai), J Cardot(Inserm), Claude Dubray(Assistance Publique – Hôpitaux de Paris)
Cited by 140
Related Papers
Mechanisms of hypersensitivity in IBS and functional disorders
|Neurogastroenterology & Motility|2007|350
Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome
|Scientific Reports|2015|326
Functional dyspepsia
|Nature Reviews Disease Primers|2017|322
Minimum standards of anorectal manometry
|Neurogastroenterology & Motility|2002|308
Selective dysfunction of mechanosensitive intestinal afferents in irritable bowel syndrome
|Gastroenterology|1995|282